BRENNER RANDALL B. (Chief Development & Regulatory) sold 1.0% of their position (3.52K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $12.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/1/2022ACC: 0000904454-22-000528
Officer· Chief Development & Regulatory
Since Sep 2019
-3.52K
Net shares
Net seller
$12.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.52K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.52K
Price / share
$3.47
Trade value
$12.20K
% of position
1.0%
10/28/2022
357.65K→354.13K
Total
Net shares
−3.52K
Net value
-$12.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/28/2022 | S · Sale | −3.52K | $3.47 | $12.20K | 1.0% | 357.65K | 354.13K |
| Total | −3.52K | -$12.20K | ||||||
Derivative Transactions0
No derivative transactions reported